Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |